ArticleNeurology and therapy2026
Spatiotemporal Heterogeneity in Isolated Neurosarcoidosis: Diagnostic Insights from Multimodal Imaging.
Article in Neurology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Isolated neurosarcoidosis (INS) is a rare inflammatory disorder of the central nervous system that lacks systemic manifestations and mimics neoplastic or infectious conditions, making diagnosis challenging. We report a case of a previously healthy 30-year-old man who presented with recurrent transient loss of consciousness and progressive right leg weakness. Brain magnetic resonance imaging (MRI) demonstrated multiple uniformly contrast-enhancing nodular lesions involving the pachymeninges and cranial nerves, while spinal MRI revealed conus medullaris enhancement with associated lumbosacral nerve root thickening. Stereotactic biopsy of an MRI-enhancing pachymeningeal lesion demonstrated chronic granulomatous inflammation, with infectious and neoplastic etiologies excluded, leading to a diagnosis of INS. Subsequent 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) revealed marked metabolic heterogeneity, with mixed hyper- and hypometabolic cerebral nodules and metabolically inactive pachymeningeal and spinal lesions. This case illustrates spatiotemporal inflammatory heterogeneity in INS and highlights multimodal imaging findings demonstrating structural-metabolic discordance. Early incorporation of PET/CT alongside MRI may provide complementary metabolic information that assists lesion characterization in diagnostically complex central nervous system inflammatory diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.